07.06.2021 • News

Nexeo Buys Italy’s Nevicolor

US-based thermoplastics distributor Nexeo Plastics has acquired Italy’s Nevicolor for an undisclosed sum.

Based in Luzzara, Nevicolor is a leading thermoplastic distributor and compounder serving a variety of customers in the industrial components, healthcare, automotive, advanced packaging, agriculture and electrical markets.

"This strategic acquisition increases GPD’s scale and affords Nexeo Plastics access to Nevicolor’s highly technical and analytical specialization,” said Paul Tayler, CEO of GPD, Nexeo’s owner.

Joost d’Hooghe, vice president of Europe, Middle East & Africa at Nexeo Plastics, added: “Our customers in Europe will now have access to a robust offering of tailor-made compounds, specialty polymers, lab services and recycled material.”

GPD is a group of global distributors formed by private equity group One Rock Capital Partner, which bought Nexeo Plastics in March 2019. At the same time, Nexeo Plastics’ parent Nexeo Solutions became part of US-based multinational distribution group Univar.

Author: Elaine Burridge, Freelance Journalist

 

Nexeo Plastics has acquired Italy’s Nevicolor for an undisclosed sum. Based...
Nexeo Plastics has acquired Italy’s Nevicolor for an undisclosed sum. Based in Luzzara, Nevicolor is a leading thermoplastic distributor and compounder serving customers in the industrial components, healthcare, automotive, advanced packaging, agriculture and electrical markets. (c) Nevicolor

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read